The Best Emerging Technologies of Tomorrow, Today.


Tuesday, February 23, 2016

1pm – 6pm | Microsoft Technology Center  |  Apply to Pitch

Top Investment Opportunities from NY’s Digital Health & Bio Technology Community.

NYC Trends…
3000+ inventions
750+ license agreements
120+ Start-ups
$225mm NYC Deals in 2015…can it be matched in 2016?

Health & Bio Technology Summit

HBTS is designed to attract a wide cross-section of the top innovators in healthcare, both locally and nationally.

You’ll come face to face with the entrepreneurs & investors who are shaping the technologies of tomorrow, today.

NYC is home to cutting edge startups, massive investment dollars and a diverse ecosystem, including universities and academic medical centers.

300+ Attendees

  • Entrepreneurs
  • Venture, angel and corporate investors
  • Sr. executives from the corporate level
  • Key industry press and analysts
  • The most connected healthcare executives
  • CEOs/Founders 55%
  • Investors 30%
  • Biz Dev 10%
  • Press 3%
  • Other 10%

Microsoft, 640 8th Avenue


Therapeutics Diagnostics Devices Big Data SaaS Mobile Wearables

HBTS is a great opportunity to showcase all of the best technology coming out of New York City. I look forward to the next event!

Tom Cirrito
Tom Cirrito
General Partner Founder & CEO, Filament

The Summit provides the ideal venue to discuss and refine our strategy by interacting with seasoned entrepreneurs and subject-matter experts. Beyond the main event, the support from the ETS/Tech Connect team translated into numerous connections to potential investors and had a direct impact on our fundraising process. Currently no other biotech-related program in NYC can provide that value and breadth of support to life sciences entrepreneurs.

Frederico Lourenco
Frederico Lourenco
Co-founder at Repairogen

VentriNova has benefited a great deal from our association with the Summit. Our presentation put us in front of New York’s biotech community so that we could tell our unique story of being the only company in the world that has demonstrated the ability to make de novo heart muscle cells in diseased heart tissue with a significant improvement in heart function. And, we met and recruited our CEO from [HBTS's] Executive-in-Residence Program!

Dr. Hina Chaudhry
Dr. Hina Chaudhry
Founder, VentriNova

Become a part of HBTS

Meet top entrepreneurs, investors and industry leaders.

Register Now